Medical specialists from Canada tagged as investigators in clinical trials studying Chronic Graft Versus Host Disease

Total 47 results

Alexander Wong
Seen in:
- Saskatchewan, Regina, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Amanda Li, MD, MSc
Seen in:
- British Columbia, Vancouver, Bc Children'S Hospital
Trials:
- NCT04372524 (Sub-Investigator)
Conditions:
Ashley Chopek
Seen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:
- NCT04759586 (Principal Investigator)
- NCT05457556 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT03223753 (Principal Investigator)
Conditions:
Bruno Michon
Seen in:
- Quebec, CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
- Quebec, Centre hospitalier universitaire de Québec
Trials:
- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT01790152 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:
Carla Coffin
Seen in:
- Alberta, Calgary, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions:
Craig Erker
Seen in:
- Nova Scotia, Halifax, IWK Health Centre
Trials:
- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT05602194 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT04089358 (Principal Investigator)
Conditions:
David Mitchell, MD
Seen in:
- Quebec, Montréal, McGill University Health Centre
Trials:
- NCT04372524 (Principal Investigator)
Conditions:
Donna L. Johnston
Seen in:
- Ontario, Ottawa, Children's Hospital of Eastern Ontario
Trials:
- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00772200 (Principal Investigator)
- NCT03223753 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:
Dylan MacKay, PhD
Seen in:
- Manitoba, Winnipeg, Chronic Disease Innovation Centre, Seven Oaks Hospital
- Manitoba, Winnipeg, Health Science Centre (HSC)
- Manitoba, Winnipeg, Richardson Center for Food Technology and Research
- Manitoba, Winnipeg, Seven Oaks General Hospital Chronic Disease Innovation Centre
Trials:
- NCT05029427 (Principal Investigator)
- NCT04961164 (Principal Investigator)
- NCT05113641 (Principal Investigator)
- NCT05090865 (Principal Investigator)
- NCT05976633 (Principal Investigator)
Conditions:
Emmanuel Charbonney, MD PhD
Seen in:
- Quebec, Montreal, Centre Hospitalier de l'Université de Montréal
Trials:
- NCT05270759 (Sub-Investigator)
Conditions:
François Maltais, MD
Seen in:
- Quebec, Québec, Institut Universitaire de Cardiologie et de Pneumologie de Québec
- Quebec, Québec, Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
- Québec, Institut Universitaire de Cardiologie et de Pneumologie de Québec
- Québec, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Universite Laval
Trials:
- NCT01902927 (Principal Investigator)
- NCT04201522 (Principal Investigator)
- NCT01909544 (Principal Investigator)
- NCT06447831 (Principal Investigator)
Conditions:
Geoffrey Gotto, MD
Seen in:
- Alberta, Calgary, Prostate Cancer Centre
- Alberta, Calgary, Prostate Cancer Centre - Rockyview Hospital
Trials:
- NCT04070209 (Principal Investigator)
- NCT05707208 (Principal Investigator)
Conditions:
Harsha Shanthanna, MD
Seen in:
- Ontario, Hamilton, St. Joseph's Healthcare Hamilton
Trials:
- NCT05167877 (Principal Investigator)
- NCT05738239 (Principal Investigator)
Conditions:
- Low Back Pain;
- Chronic Pain;
- Pain
Henrique Bittencourt, MD, PhD
Seen in:
- Quebec, Montreal, Chu St Justine
- Quebec, Montréal, CHU Sainte-Justine
Trials:
- NCT04372524 (Principal Investigator)
- NCT01257854 (Principal Investigator)
Conditions:
Jacob Rozmus, MD, PhD
Seen in:
- British Columbia, Vancouver, Bc Children'S Hospital
Trials:
- NCT04372524 (Sub-Investigator)
Conditions:
Jason T. Szabo
Seen in:
- Quebec, Montreal, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05917509 (Principal Investigator)
- NCT06039579 (Principal Investigator)
Conditions:
Jean-Baptiste Lattouf, MD
Seen in:
- Quebec, Montréal, THEO Medical
Trials:
- NCT05707208 (Principal Investigator)
Conditions:
- Chronic Pain
Jean-François Cailhier, MD PhD
Seen in:
- Quebec, Montreal, Centre Hospitalier de l'Université de Montréal
Trials:
- NCT05270759 (Sub-Investigator)
Conditions:
Jennifer Locke, MD
Seen in:
- British Columbia, Kelowna, Kelowna General Hospital Clinical Research Department
Trials:
- NCT05707208 (Principal Investigator)
Conditions:
- Chronic Pain
Jennifer White
Seen in:
- British Columbia, Vancouver, Vancouver General Hospital/BC Cancer
Trials:
- NCT04431479 (Principal Investigator)
Conditions:
- Chronic Graft Versus Host Disease
Jonathan Giddens, MD
Seen in:
- Ontario, Brampton, Jonathan Giddens Medicine Professional Corporation
Trials:
- NCT04097002 (Principal Investigator)
- NCT05707208 (Principal Investigator)
Conditions:
- Adenocarcinoma of the Prostate;
- Chronic Pain
Julie Zhu
Seen in:
- Nova Scotia, Halifax, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Karen Doucette
Seen in:
- Alberta, Edmonton, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05921903 (Principal Investigator)
Conditions:
Keith Jarvi, MD
Seen in:
- Ontario, Toronto, Mount Sinai Hospital - Men's Health Institute
Trials:
- NCT05707208 (Principal Investigator)
Conditions:
- Chronic Pain
Kirk R. Schultz, MD
Seen in:
- British Columbia, Vancouver, Bc Children'S Hospital
Trials:
- NCT04372524 (Principal Investigator)
Conditions:
Lambert Busque, MD
Seen in:
- Quebec, Montréal, Hôpital Maisonneuve-Rosemont (CIUSSS EMTL)
Trials:
- NCT05413915 (Principal Investigator)
Conditions:
Luke Witherspoon, MD
Seen in:
- Ontario, Ottawa, Ottawa Hospital Research Institute
Trials:
- NCT05707208 (Principal Investigator)
Conditions:
- Chronic Pain
Magdy Elkhashab
Seen in:
- Ontario, Toronto, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Mang Ming Ma
Seen in:
- Alberta, Edmonton, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
Conditions:
- Chronic Hepatitis B;
- Hepatitis B, Chronic
Monia Marzouki
Seen in:
- Quebec, Montreal, Centre Hospitalier Universitaire Sainte-Justine
Trials:
- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT03155620 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT05071209 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT05286801 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05359237 (Principal Investigator)
- NCT04203316 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT05828069 (Principal Investigator)
Conditions:

Clinical Trials on Chronic Graft Versus Host Disease

University of Liege

Terminated

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Chronic Graft-Versus-Host Disease | Acute Graft-Versus-Host Disease | Steroid Refractory Graft-Versus-Host Disease

Belgium
Grupo Espanol de trasplantes hematopoyeticos y...

Completed

Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell. (CSM/EICH2010)

Chronic Graft-Versus-Host Disease

Spain
Hospital Universitario Dr. Jose E. Gonzalez

Recruiting

Efficacy and Safety of Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease

Chronic Graft-versus-host-disease

Mexico
Shanghai General Hospital, Shanghai Jiao Tong University...

Terminated

Anlotinib Treatment in Steroid Depenent/Refractory cGVHD

Chronic Graft-versus-host-disease

China
Universitätsklinikum Hamburg-Eppendorf
Novartis; Crolll Gmbh

Completed

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus (PredEver first)

Chronic Graft-versus-host Disease

Germany
Gruppo Italiano Trapianto di Midollo Osseo

Completed

A Prospective Observational Study for Evaluating CGVHD (GITMO-GVCrOSy)

Chronic Graft-Versus-Host Disease

Italy
Medsenic

Completed

Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide (GvHD-ATO)

Immune System Diseases | Chronic Graft-Versus-Host Disease
SCRI Development Innovations, LLC
Novartis

Withdrawn

A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease

Chronic Graft-Versus-Host Disease

United States
Brigham and Women's Hospital
Massachusetts General Hospital; Dana-Farber Cancer Institute; Beth Israel Deaconess... and other collaborators

Completed

Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease

Oral Chronic Graft-versus-host Disease

United States
Brigham and Women's Hospital
Dana-Farber Cancer Institute

Terminated

UVB Phototherapy Treatment of Oral Chronic GVHD

Oral Chronic Graft-Versus-Host Disease

United States

Medical specialists from Canada tagged as investigators in clinical trials studying Chronic Graft Versus Host Disease

Clinical Trials on Chronic Graft Versus Host Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations